BAXTER INTERNATIONAL INC BAX

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $26.73
Market Cap $13.97B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑5.7% YoY
$11.24B
3-Yr CAGR: -9.4%
Net Income ↓-47.5% YoY
-$957.00M
Net Margin: -8.5%
Free Cash Flow ↓-42.1% YoY
$332.00M
FCF Yield: 2.38%
EPS (Diluted) ↓-47.2% YoY
$-1.87
Basic: $-1.87
Return on Equity Efficiency
-15.6%
ROA: -117.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (BAX)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $10,163.0M $4,110.0M $4,965.0M $9.01 $1,654.0M $935.0M
FY 2017 $10,561.0M +3.9% $4,462.0M $717.0M -85.6% $1.29 -85.7% $1,837.0M $1,203.0M +28.7%
FY 2018 $11,127.0M +5.4% $4,781.0M $1,624.0M +126.5% $2.97 +130.2% $2,096.0M $1,415.0M +17.6%
FY 2019 $11,362.0M +2.1% $4,761.0M $1,001.0M -38.4% $1.93 -35.0% $2,104.0M $1,408.0M -0.5%
FY 2020 $11,673.0M +2.7% $4,587.0M $1,102.0M +10.1% $2.13 +10.4% $1,868.0M $1,159.0M -17.7%
FY 2021 $12,784.0M +9.5% $5,105.0M $1,284.0M +16.5% $2.53 +18.8% $2,222.0M $1,479.0M +27.6%
FY 2022 $15,113.0M +18.2% $5,397.0M $-2,433.0M -289.5% $-4.83 -290.9% $1,211.0M $834.0M -43.6%
FY 2023 $14,813.0M -2.0% $4,975.0M $2,656.0M +209.2% $5.25 +208.7% $1,726.0M $1,294.0M +55.2%
FY 2024 $10,636.0M -28.2% $3,984.0M $-649.0M -124.4% $-1.27 -124.2% $1,019.0M $573.0M -55.7%
FY 2025 $11,244.0M +5.7% $3,379.0M $-957.0M -47.5% $-1.87 -47.2% $845.0M $332.0M -42.1%
$

Valuation

Market Price $26.73
Market Cap $13.97B
Enterprise Value $21.44B
P/E Ratio N/A
P/B Ratio 2.25
FCF Yield 2.38%
Dividend Yield 1.95%
Shares Outstanding 516,469,000
%

Profitability & Margins

Gross Margin 30.05%
Operating Margin -2.74%
Net Margin -8.51%
Return on Equity (ROE) -15.61%
Return on Assets (ROA) -117.71%
Asset Turnover 13.83x
Revenue 3-Yr CAGR -9.39%
🛡️

Financial Health & Liquidity

Current Ratio 0.41
Cash Ratio 1.00
Debt / Equity 1.540
Debt / Assets 11.609
Cash & Equivalents $1.97B
Total Debt $9.44B
Book Value / Share $11.87
💧

Cash Flow Efficiency

Operating Cash Flow $845.00M
Capital Expenditures (CapEx) $513.00M
Free Cash Flow $332.00M
OCF / Revenue 7.52%
FCF / Revenue 2.95%
FCF 3-Yr CAGR -26.44%
🏷️

Per Share Metrics

EPS (Diluted) $-1.87
EPS (Basic) $-1.87
Dividends / Share $0.52
Book Value / Share $11.87
EPS YoY Growth -47.24%
🏛️

Balance Sheet (FY 2025)

Total Assets $813.00M
Total Liabilities $1.97B
Stockholders' Equity $6.13B
Current Assets $813.00M
Current Liabilities $1.97B